相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice
Xin Li et al.
MICROBIAL BIOTECHNOLOGY (2022)
Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding
Yixin Shi et al.
NANOMATERIALS (2022)
A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
Bo Liu et al.
ENGINEERING (2022)
A conserved region of Acinetobacter trimeric autotransporter adhesion, Ata, provokes suppression of Acinetobacter baumannii virulence
Ramin Hatefi Oskuei et al.
ARCHIVES OF MICROBIOLOGY (2021)
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update
Guan-Huei Lee et al.
EXPERT REVIEW OF VACCINES (2021)
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Ioannis Kyriakidis et al.
PATHOGENS (2021)
Prophylactic vaccine delivery systems against epidemic infectious diseases
Chao Pan et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development
NorAziyah Mat Rahim et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
The Acinetobacter baumannii Autotransporter Adhesin Ata Recognizes Host Glycans as High-Affinity Receptors
Greg Tram et al.
ACS INFECTIOUS DISEASES (2021)
Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host
Zhehui Peng et al.
ADVANCED SCIENCE (2021)
Expression of Bordetella pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines
Han Xu et al.
VACCINES (2021)
Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus
Jing Huang et al.
MICROORGANISMS (2020)
Biosynthesis of Self-Assembled Proteinaceous Nanoparticles for Vaccination
Chao Pan et al.
ADVANCED MATERIALS (2020)
Managing Acinetobacter baumannii infections
Jose Garnacho-Montero et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Trimeric autotransporter adhesins in Acinetobacter baumannii, coincidental evolution at work
Mohammad Reza Rahbar et al.
INFECTION GENETICS AND EVOLUTION (2019)
A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice
X. Zeng et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
On the mechanisms of conjugate vaccines
Rino Rappuoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii
Marko Weidensdorfer et al.
VIRULENCE (2019)
Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study
Shuangshuang Yang et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2018)
Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo
Peng Sun et al.
NPJ VACCINES (2018)
Glycoconjugate vaccines: Principles and mechanisms
Rino Rappuoli
SCIENCE TRANSLATIONAL MEDICINE (2018)
Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection
Sarah Ainsworth et al.
VACCINE (2017)
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
Chang-Ro Lee et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii
Ravinder Singh et al.
SCIENTIFIC REPORTS (2017)
Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System
Chao Pan et al.
MBIO (2016)
Immunoprotective Efficacy of Acinetobacter baumannil Outer Membrane Protein, FiIF, Predicted In silico as a Potential Vaccine Candidate
Ravinder Singh et al.
FRONTIERS IN MICROBIOLOGY (2016)
A domain dictionary of trimeric autotransporter adhesins
Jens Bassler et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants
Jinyoung Lee et al.
PARASITOLOGY RESEARCH (2015)
OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections
Weiwei Huang et al.
VACCINE (2015)
Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
Keegan J. Baldauf et al.
TOXINS (2015)
Cholera Toxin Subunit B as Adjuvant-An Accelerator in Protective Immunity and a Break in Autoimmunity
Thomas Stratmann
VACCINES (2015)
Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism
Xiaobo Lv et al.
VACCINE (2014)
Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice
Jue Hou et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Immunogenicity of a West Nile Virus DIII-Cholera Toxin A2/B Chimera after Intranasal Delivery
Juliette K. Tinker et al.
TOXINS (2014)
Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital
L. Silvia Munoz-Price et al.
CRITICAL CARE MEDICINE (2013)
Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes
Johanna J. Kenyon et al.
PLOS ONE (2013)
Diversity in the Major Polysaccharide Antigen of Acinetobacter Baumannii Assessed by DNA Sequencing, and Development of a Molecular Serotyping Scheme
Dalong Hu et al.
PLOS ONE (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Evaluation of the Trimeric Autotransporter Ata as a Vaccine Candidate against Acinetobacter baumannii Infections
Leticia V. Bentancor et al.
INFECTION AND IMMUNITY (2012)
Identification of Ata, a Multifunctional Trimeric Autotransporter of Acinetobacter baumannii
Leticia V. Bentancor et al.
JOURNAL OF BACTERIOLOGY (2012)
Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection
Guanpingshen Luo et al.
PLOS ONE (2012)
AtaA, a New Member of the Trimeric Autotransporter Adhesins from Acinetobacter sp Tol 5 Mediating High Adhesiveness to Various Abiotic Surfaces
Masahito Ishikawa et al.
PLOS ONE (2012)
Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii
Michael J. McConnell et al.
INFECTION AND IMMUNITY (2011)
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
Fikri Y. Avci et al.
NATURE MEDICINE (2011)
Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap)
Yaser Fattahian et al.
MICROBIAL PATHOGENESIS (2011)
Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii
Michael J. McConnell et al.
VACCINE (2011)
Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine
Michael J. McConnell et al.
VACCINE (2010)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H-Pylori in mice
J. Nystrom-Asklin et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
The epidemiology and control of Acinetobacter baumannii in health care facilities
PE Fournier et al.
CLINICAL INFECTIOUS DISEASES (2006)
Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems
T Harakuni et al.
INFECTION AND IMMUNITY (2005)
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
J Holmgren et al.
IMMUNOLOGY LETTERS (2005)
Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity
I Isomura et al.
MICROBIOLOGY AND IMMUNOLOGY (2005)
Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor
K Eriksson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development
K Eriksson et al.
INFECTION AND IMMUNITY (2003)
Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses
F Anjuère et al.
JOURNAL OF IMMUNOLOGY (2003)
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection
AM Harandi et al.
JOURNAL OF VIROLOGY (2003)
Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells
A George-Chandy et al.
INFECTION AND IMMUNITY (2001)
分享论文
